Herlea-Pana et al. found that endothelial progenitor cells (EPC) express CXCR2, the receptor of CXCL1, and can be recruited to the plaque site in the late stage of atherosclerosis to accelerate plaque regression. The gene discussed is CXCR2; the disease is atherosclerosis.